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Abstract 
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Gothenburg, Sweden 2009. 
 
Resistin is a protein with proinflammatory properties in man and a regulator of glucose 
metabolism in mice. Human resistin activates the nuclear factor kappa-B dependent 
cytokine cascade; however, its full role in inflammation in terms of regulation, 
expression, and cellular source is not entirely understood. Resistin may have a role in 
insulin growth factor signaling. The main aim of this thesis was to investigate the role 
of resistin in inflammation, with emphasis on rheumatic diseases and diseases of the 
liver and gastrointestinal tract; in addition, the neutrophil was evaluated as a possible 
source of resistin. Another aim was to investigate the effect of resistin on IGF 
signaling in a new mouse model of arthritis.  
 
In paper I, resistin was shown to be associated with local inflammation in patients with 
primary Sjögren’s syndrome. This conclusion was based on the finding of elevated 
resistin levels in saliva and in the salivary gland tissue of patients. Moreover, resistin 
levels were significantly higher in patients with high focal infiltration of leukocytes in 
glandular tissue than in those with no or low leukocyte infiltration. In paper II, resistin 
levels were found to be elevated in a wide variety of inflammatory and autoimmune 
conditions of the liver and gastrointestinal tract. Furthermore, they were significantly 
higher in patients who were seropositive for anti-nuclear antibodies than those who 
were seronegative. In paper III, a new cell source of resistin in inflammation was 
identified, namely the neutrophil. Subcellular fractionation of the neutrophil confirmed 
the presence of resistin in the azurophil granules and the specific granules. In a 
rheumatoid arthritis (RA) model in paper IV, resistin was shown to modulate IGF 
signaling. Levels of IGF-1 were significantly lower in RA patients, especially those 
with systemic inflammation, than in controls with non-inflammatory joint conditions, 
and they were inversely related to resistin levels. Resistin expression was abrogated in 
a transplantation mouse model of RA synovia. This led to downregulation of IGF-1R 
expression and intracellular Akt activity.  
 
Taken together, these results indicate that resistin is an immunomodulatory molecule 
that is expressed locally at the site of inflammation. It is produced by neutrophils and 
possibly modulates IGF signaling. These findings suggest that resistin regulates both 
inflammation and could affect growth factor-related signaling in humans.  
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